A 28-year-old woman presents to the outpatient clinic with a 3-week history of polyuria, polydipsia, and weight loss of 4 kg. She reports recent onset of fatigue and blurred vision. On examination, she appears lean (BMI 21 kg/m²). Laboratory investigations reveal: fasting blood glucose 280 mg/dL, HbA1c 9.2%, venous pH 7.28, serum bicarbonate 16 mEq/L, and positive serum ketones. C-peptide level is 0.3 ng/mL (normal 0.8–3.1). Anti-GAD and anti-IA2 antibodies are positive. What is the most appropriate initial management?

Explanation

## Clinical Diagnosis: Type 1 Diabetes Mellitus with Diabetic Ketoacidosis (DKA) ### Key Diagnostic Features | Feature | Finding | Significance | |---------|---------|---------------| | **Age & presentation** | 28 years, acute onset | Classic Type 1 presentation | | **BMI** | 21 kg/m² (lean) | Argues against Type 2 | | **Metabolic derangement** | pH 7.28, HCO₃ 16 mEq/L, ketones+ | DKA present | | **C-peptide** | 0.3 ng/mL (very low) | Severe β-cell dysfunction | | **Autoimmunity** | Anti-GAD, anti-IA2 positive | Autoimmune Type 1 DM | **Key Point:** The combination of acute presentation, lean body habitus, positive autoantibodies, low C-peptide, and metabolic acidosis with ketonemia is pathognomonic for Type 1 DM in DKA. ### Why Insulin Is Mandatory 1. **Absolute insulin deficiency**: C-peptide 0.3 ng/mL indicates severe β-cell failure; oral agents cannot work without functional β-cells. 2. **DKA is life-threatening**: Requires immediate insulin infusion (0.1 U/kg/hr IV) to suppress lipolysis and ketone production. 3. **Hospitalization criteria met**: Venous pH < 7.30, symptomatic hyperglycemia, metabolic acidosis, and risk of progression to severe DKA. **High-Yield:** Type 1 DM + DKA = insulin is not optional; it is the only effective therapy and must be given parenterally (IV or SC) in acute settings. ### Management Algorithm ```mermaid flowchart TD A[Type 1 DM with DKA]:::urgent --> B{Severity?}:::decision B -->|Mild-moderate DKA| C[IV insulin infusion + fluids]:::action B -->|Severe DKA| D[ICU admission + aggressive IV insulin]:::action C --> E[Monitor glucose, electrolytes, pH q1-2h]:::action D --> E E --> F[Once stable, transition to basal-bolus SC insulin]:::action F --> G[Long-term: MDI or CSII + diabetes education]:::outcome ``` **Clinical Pearl:** Even mild DKA (pH 7.25–7.30) requires hospitalization and IV insulin; outpatient management is unsafe in Type 1 DM with ketosis. **Mnemonic: DKA Management = "FLUID-INSULIN-MONITOR"** - **F**luids (0.9% NaCl) - **L**ow-dose insulin infusion (0.1 U/kg/hr) - **U**rinary ketones & serum glucose q1-2h - **I**nsulin drip until pH ≥ 7.30 - **D**iscontinue when oral intake tolerated - **I**nitiate SC insulin before stopping IV - **N**utritional support - **S**odium & potassium replacement as needed - **U**nderstanding: This is Type 1 DM — lifelong insulin required - **L**ong-term: Basal-bolus or pump therapy - **I**nsulin education & carb counting - **N**ew diagnosis → endocrinology referral - **S**upport groups & psychological counseling [cite:Harrison 21e Ch 397] [cite:KD Tripathi 8e Ch 12]